Literature DB >> 26254984

Pediatric cervicofacial lymphadenitis caused by Bartonella henselae.

Jerome A Lindeboom1.   

Abstract

BACKGROUND: Chronic cervicofacial lymphadenitis in children is often caused by nontuberculous mycobacterium or Bartonella henselae species (known as cat scratch disease).
METHODS: Bartonella henselae infection was diagnosed in 53 of 427 children with cervicofacial lymphadenopathy by polymerase chain reaction.
RESULTS: The age of patients ranged from 16 to 148 months (median, 59 months), 28 (53%) were male, and 25 were female (47%). The submandibular lymph nodes were most commonly affected (92%). Patients were not treated with antibiotics. In 11 (21%) patients, aspiration of pus was performed to facilitate drainage, which led to a mean resolution of 5 ± 3.1 months compared with a mean resolution time of 8.2 ± 3.8 months for 40 patients treated with a wait-and-see policy (P = .01).
CONCLUSIONS: Bartonella henselae is a common pathogen in children with chronic cervicofacial lymphadenitis. Treatment usually involves a wait-and-see approach, but in selected cases, aspiration may be needed for symptomatic relief.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26254984     DOI: 10.1016/j.oooo.2015.06.031

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  2 in total

1.  From Benign to Malign in a Case of Cervical Adenopathy in a 17-Year-Old Adolescent: Diagnostic Traps.

Authors:  Simona Dumitra; Maria Trailescu; Amelia Burlea; Claudia Covaci; Ozana Balan; Adrian Pavel; Carmen Crișan
Journal:  Case Rep Pediatr       Date:  2016-11-27

2.  Serological and molecular detection of Bartonella henselae in specimens from patients with suspected cat scratch disease in Italy: A comparative study.

Authors:  Valeria Allizond; Cristina Costa; Francesca Sidoti; Sara Scutera; Gabriele Bianco; Rosaria Sparti; Giuliana Banche; Paola Dalmasso; Anna Maria Cuffini; Rossana Cavallo; Tiziana Musso
Journal:  PLoS One       Date:  2019-02-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.